TickerFacts.

Lantern Pharma Inc. (LTRN): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

10.90M
Year ended 2025-12-31
+0.1%
3-year compound annual growth
2022-12-31: 10.85M2023-12-31: 10.84M2024-12-31: 10.76M2025-12-31: 10.90M10.90M
2022-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3110.90M+1.3%2026-03-30, From 2025-01-01
2024-12-3110.76M-0.7%2026-03-30, From 2024-01-01
2023-12-3110.84M-0.1%2025-03-27, From 2023-01-01
2022-12-3110.85Mn/a2024-03-18, From 2022-01-01